Funder transparency policies
Around half of all clinical trials never make their results public, leaving large gaps in the medical evidence basis. Medical research funders have the opportunity to promote transparency, reduce research waste, and prevent publication bias by adopting policies that require researchers that they fund to appropriately register clinical trials and report their results, as well as by continued monitoring of researchers’ registration and reporting performance.
This study assesses to what extent the policies and monitoring systems of the 21 largest public and philanthropic medical research funders (excluding multilateral funders) in Europe meet global best practice benchmarks as stipulated by the WHO Joint Statement.
We will assess the policies and monitoring systems based on information provided on funder websites, followed by validation with funding institutions themselves.
Protocol and assessment tools can be found here.
As a result, we anticipate a ranking of 21 funders according to the strength of their transparency policies. We will identify strengths and weaknesses of each individual funder.